1. Home
  2. CNTX vs NMS Comparison

CNTX vs NMS Comparison

Compare CNTX & NMS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CNTX
  • NMS
  • Stock Information
  • Founded
  • CNTX 2015
  • NMS 1993
  • Country
  • CNTX United States
  • NMS United States
  • Employees
  • CNTX N/A
  • NMS N/A
  • Industry
  • CNTX Biotechnology: Pharmaceutical Preparations
  • NMS Finance Companies
  • Sector
  • CNTX Health Care
  • NMS Finance
  • Exchange
  • CNTX Nasdaq
  • NMS Nasdaq
  • Market Cap
  • CNTX 78.0M
  • NMS 66.4M
  • IPO Year
  • CNTX 2021
  • NMS N/A
  • Fundamental
  • Price
  • CNTX $0.63
  • NMS $11.45
  • Analyst Decision
  • CNTX Strong Buy
  • NMS
  • Analyst Count
  • CNTX 5
  • NMS 0
  • Target Price
  • CNTX $5.50
  • NMS N/A
  • AVG Volume (30 Days)
  • CNTX 330.3K
  • NMS 12.0K
  • Earning Date
  • CNTX 08-06-2025
  • NMS 01-01-0001
  • Dividend Yield
  • CNTX N/A
  • NMS 4.11%
  • EPS Growth
  • CNTX N/A
  • NMS N/A
  • EPS
  • CNTX N/A
  • NMS N/A
  • Revenue
  • CNTX N/A
  • NMS N/A
  • Revenue This Year
  • CNTX N/A
  • NMS N/A
  • Revenue Next Year
  • CNTX N/A
  • NMS N/A
  • P/E Ratio
  • CNTX N/A
  • NMS N/A
  • Revenue Growth
  • CNTX N/A
  • NMS N/A
  • 52 Week Low
  • CNTX $0.49
  • NMS $9.21
  • 52 Week High
  • CNTX $2.75
  • NMS $12.18
  • Technical
  • Relative Strength Index (RSI)
  • CNTX 50.76
  • NMS 53.15
  • Support Level
  • CNTX $0.62
  • NMS $11.31
  • Resistance Level
  • CNTX $0.70
  • NMS $11.43
  • Average True Range (ATR)
  • CNTX 0.05
  • NMS 0.08
  • MACD
  • CNTX 0.01
  • NMS 0.02
  • Stochastic Oscillator
  • CNTX 56.44
  • NMS 78.73

About CNTX Context Therapeutics Inc.

Context Therapeutics Inc is a clinical-stage biopharmaceutical company advancing medicines for solid tumors. The development team is advancing a pipeline of various therapies with a primary focus on treating female, hormone-dependent cancer, including breast, ovarian, and endometrial cancer. The company's preclinical program, CTIM-76, is an anti-Claudin 6 (CLDN6) x anti-CD3 bispecific antibody (bsAb) that is intended to redirect T-cell-mediated lysis toward malignant cells expressing CLDN6.

About NMS Nuveen Minnesota Quality Municipal Income Fund

Nuveen Minnesota Quality Municipal Income Fund is a diversified closed-end management investment company. The Fund's primary investment objective is current income exempt from both regular federal income taxes and Minnesota state income taxes and its secondary investment objective is the enhancement of portfolio value.

Share on Social Networks: